What medications can help with sleep disturbances in an adult patient with a history of marijuana (cannabis) use who has recently stopped smoking?

Medication Management for Sleep Disturbances After Cannabis Cessation

For adults experiencing sleep problems after stopping marijuana, cognitive behavioral therapy for insomnia (CBT-I) should be the first-line treatment, with low-dose trazodone (50-100mg at bedtime) as the preferred pharmacological option if behavioral interventions alone are insufficient. 1, 2

Understanding Cannabis Withdrawal and Sleep

Sleep disturbance is a well-documented withdrawal symptom that occurs within 3 days of cannabis cessation and typically lasts up to 14 days. 3 The specific sleep disruptions include:

• Reduced total sleep time and sleep efficiency 4
• Increased wake time after sleep onset 4
• Decreased REM sleep 4
• Increased periodic limb movements, particularly in those with heavier and longer duration of use 4

These objective polysomnographic findings confirm that cannabis withdrawal genuinely disrupts sleep architecture, not just subjective perception. 4, 5

First-Line Treatment: Behavioral Interventions

Cognitive behavioral therapy for insomnia (CBT-I) is the most effective treatment with sustained benefits and should be initiated immediately. 1, 6, 7 This approach is superior to medications because:

• Effects are sustained for up to 2 years after treatment 6
• No risk of dependence or withdrawal 1
• Addresses perpetuating factors like conditioned arousal and maladaptive sleep behaviors 1

Essential Sleep Hygiene Components

• Regular sleep-wake schedule with consistent bed and wake times 6, 8
• Morning or afternoon exercise and daytime bright light exposure 8, 9
• Avoid heavy meals, alcohol, and caffeine (last caffeine dose before 4:00 PM) 6, 9
• Dark, quiet, comfortable sleep environment 9
• Short naps (15-20 minutes) around noon if needed for daytime sleepiness 9

Pharmacological Options When Behavioral Therapy Is Insufficient

Trazodone: The Preferred Medication

Trazodone 50-100mg at bedtime is the most appropriate pharmacological choice for cannabis withdrawal-related insomnia. 2 This recommendation is based on:

• Sedating antidepressant properties without benzodiazepine-related risks 2
• Lower abuse potential compared to hypnotics 2
• Dual benefit for comorbid anxiety or depression, which commonly accompany cannabis use disorder 3

Key prescribing considerations for trazodone:

• Take shortly after a meal or light snack to optimize absorption 2
• Start with lowest effective dose 2
• Can be broken in half along score line but should not be crushed or chewed 2
• Monitor for orthostatic hypotension, especially in first few days 2
• Avoid in patients taking MAOIs or within 2 weeks of MAOI discontinuation 2

Zolpidem: Limited Evidence in Cannabis Withdrawal

A 2024 randomized controlled trial specifically tested extended-release zolpidem for cannabis use disorder and found:

• Zolpidem-XR attenuated sleep disturbance during week 1 of abstinence 10
• Sleep problems emerged after medication discontinuation 10
• No statistically significant improvement in abstinence rates (27% vs 15% with placebo) 10
• Poor medication adherence and high dropout rates (50%) 10

This evidence suggests zolpidem provides only temporary relief and may create rebound insomnia when stopped. 10

Medications to Avoid

Benzodiazepines should be avoided due to:

• High risk of dependence and abuse, particularly problematic in patients with substance use history 6, 8
• Risk of falls, confusion, and cognitive impairment 8
• Withdrawal seizure risk upon discontinuation 8

Long-acting benzodiazepines are particularly problematic and characterized by accumulation and prolonged sedation. 7

Clinical Algorithm for Treatment Selection

1. Weeks 1-2 of cannabis abstinence:

   • Initiate CBT-I immediately 1, 6
   • Implement comprehensive sleep hygiene 6, 8
   • Educate patient that withdrawal symptoms typically resolve within 14 days 3

2. If severe daytime impairment persists beyond 1 week:

   • Add trazodone 50mg at bedtime 2
   • Titrate to 100mg if insufficient response after 3-5 days 2
   • Continue CBT-I concurrently 7

3. If symptoms persist beyond 4 weeks:

   • Reassess for comorbid psychiatric conditions (depression, anxiety) 3, 6
   • Screen for primary sleep disorders (sleep apnea, restless legs syndrome) 8, 9
   • Consider referral to sleep specialist 9

Critical Pitfalls to Avoid

Never start with pharmacotherapy alone without concurrent behavioral interventions, as this creates dependence on medication without addressing perpetuating factors. 1, 8

Do not prescribe hypnotics for longer than 4 weeks without reassessment, as long-term use leads to tolerance and dependence. 7

Avoid antihistamines (e.g., diphenhydramine) despite over-the-counter availability, as they cause daytime sedation, delirium risk, and anticholinergic effects. 7

Screen for cannabis use disorder (present in 10% of chronic users), as untreated addiction will lead to relapse, often triggered by sleep disturbance itself. 3, 11

Monitoring and Follow-Up

• Reassess sleep quality weekly during first month using validated tools like Insomnia Severity Index 10
• Monitor for medication side effects: dizziness, daytime sedation, orthostatic hypotension with trazodone 2
• Plan medication taper after 4-8 weeks if sleep normalizes, to avoid creating new dependence 7
• Continue CBT-I even after medication discontinuation to maintain gains 6

The goal is time-limited pharmacotherapy that bridges the acute withdrawal period while behavioral interventions take effect, preventing relapse to cannabis use driven by sleep disturbance. 11, 10